Exact Mass: 707.289

Exact Mass Matches: 707.289

Found 15 metabolites which its exact mass value is equals to given mass value 707.289, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Met Trp Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C38H41N7O5S (707.289)

Trp Met Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C38H41N7O5S (707.289)

Trp Trp Met Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-(1H-indol-3-yl)propanoic acid

C38H41N7O5S (707.289)

Trp Trp Trp Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C38H41N7O5S (707.289)

5-O-DMT-2-O-MOE-N4-Bz-rC

C40H41N3O9 (707.2843)

Dihydroergocristine mesylate

C36H45N5O8S (707.2989)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

beta-D-Manp-(1->3)-beta-D-Manp-(1->3)-alpha-L-Rhap-(1->3)-beta-D-GlcpO[CH2]3NH2

C27H49NO20 (707.2848)

8-benzyl-10,17,24-trihydroxy-15-isopropyl-26-methyl-22-(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,11,14(30),16,21(29),23-heptaen-7-one

8-benzyl-10,17,24-trihydroxy-15-isopropyl-26-methyl-22-(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,11,14(30),16,21(29),23-heptaen-7-one

C35H45N7O5S2 (707.2923)

(2s,8r,15r,18r,22s,25s,26r)-8-benzyl-10,17,24-trihydroxy-15-isopropyl-26-methyl-22-(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,11,14(30),16,21(29),23-heptaen-7-one

(2s,8r,15r,18r,22s,25s,26r)-8-benzyl-10,17,24-trihydroxy-15-isopropyl-26-methyl-22-(sec-butyl)-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,11,14(30),16,21(29),23-heptaen-7-one

C35H45N7O5S2 (707.2923)

2,7-bis(acetyloxy)-8-(benzoyloxy)-6-hydroxy-5,5,9,13-tetramethyl-12-[(methylamino)methyl]-14-oxo-15,16-dioxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl benzoate

C38H45NO12 (707.2942)

(1s,2r,4s,6s,7s,8r,9s,10s,11r,12s,13r)-2,7-bis(acetyloxy)-8-(benzoyloxy)-6-hydroxy-5,5,9,13-tetramethyl-12-[(methylamino)methyl]-14-oxo-15,16-dioxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl benzoate

(1s,2r,4s,6s,7s,8r,9s,10s,11r,12s,13r)-2,7-bis(acetyloxy)-8-(benzoyloxy)-6-hydroxy-5,5,9,13-tetramethyl-12-[(methylamino)methyl]-14-oxo-15,16-dioxatetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl benzoate

C38H45NO12 (707.2942)

(2s,8r,15r,18r,22s,25s,26r)-8-benzyl-22-[(2s)-butan-2-yl]-10,17,24-trihydroxy-15-isopropyl-26-methyl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,11,14(30),16,21(29),23-heptaen-7-one

(2s,8r,15r,18r,22s,25s,26r)-8-benzyl-22-[(2s)-butan-2-yl]-10,17,24-trihydroxy-15-isopropyl-26-methyl-27-oxa-13,20-dithia-6,9,16,23,28,29,30-heptaazapentacyclo[23.2.1.1¹¹,¹⁴.1¹⁸,²¹.0²,⁶]triaconta-1(28),9,11,14(30),16,21(29),23-heptaen-7-one

C35H45N7O5S2 (707.2923)